2022
DOI: 10.3389/fpsyt.2022.958994
|View full text |Cite
|
Sign up to set email alerts
|

The aberrant dynamic amplitude of low-frequency fluctuations in melancholic major depressive disorder with insomnia

Abstract: BackgroundInsomnia is considered one of the manifestations of sleep disorders, and its intensity is linked to the treatment effect or suicidal thoughts. Major depressive disorder (MDD) is classified into various subtypes due to heterogeneous symptoms. Melancholic MDD has been considered one of the most common subtypes with special sleep features. However, the brain functional mechanisms in melancholic MDD with insomnia remain unclear.Materials and methodsMelancholic MDD and healthy controls (HCs, n = 46) were … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 80 publications
0
1
0
Order By: Relevance
“…For future studies, it is therefore recommended to evaluate a narrow selection of biomarkers including CRP [18,37,38], IL−6 [18,20,37,38], BDNF [26,42], and more detailed measures of HPA-axis (re)activity [27,[44][45][46]. Third, while the insomnia items of the QIDS-SR 16 [36,[55][56][57] and other depression scales [58][59][60] are commonly used to assess insomnia severity, this approach allows for relatively little variation compared to validated insomnia questionnaires. Future studies should therefore incorporate questionnaires that are specifically developed for the assessment of insomnia severity.…”
Section: Limitations and Future Directionsmentioning
confidence: 99%
“…For future studies, it is therefore recommended to evaluate a narrow selection of biomarkers including CRP [18,37,38], IL−6 [18,20,37,38], BDNF [26,42], and more detailed measures of HPA-axis (re)activity [27,[44][45][46]. Third, while the insomnia items of the QIDS-SR 16 [36,[55][56][57] and other depression scales [58][59][60] are commonly used to assess insomnia severity, this approach allows for relatively little variation compared to validated insomnia questionnaires. Future studies should therefore incorporate questionnaires that are specifically developed for the assessment of insomnia severity.…”
Section: Limitations and Future Directionsmentioning
confidence: 99%